Chemoinformaics analysis of (2E,6E)-hedycaryol
Molecular Weight | 222.372 | nRot | 1 |
Heavy Atom Molecular Weight | 196.164 | nRig | 10 |
Exact Molecular Weight | 222.198 | nRing | 1 |
Solubility: LogS | -3.333 | nHRing | 0 |
Solubility: LogP | 5.49 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 43.1886 |
nHD | 1 | BPOL | 26.0834 |
QED | 0.658 |
Synth | 3.749 |
Natural Product Likeliness | 2.279 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.158 |
Pgp-sub | 0.001 |
HIA | 0.003 |
CACO-2 | -4.331 |
MDCK | 0.0000144 |
BBB | 0.503 |
PPB | 0.970872 |
VDSS | 3.661 |
FU | 0.0326621 |
CYP1A2-inh | 0.2 |
CYP1A2-sub | 0.262 |
CYP2c19-inh | 0.179 |
CYP2c19-sub | 0.702 |
CYP2c9-inh | 0.243 |
CYP2c9-sub | 0.922 |
CYP2d6-inh | 0.013 |
CYP2d6-sub | 0.164 |
CYP3a4-inh | 0.083 |
CYP3a4-sub | 0.194 |
CL | 9.67 |
T12 | 0.2 |
hERG | 0.009 |
Ames | 0.001 |
ROA | 0.007 |
SkinSen | 0.841 |
Carcinogencity | 0.771 |
EI | 0.96 |
Respiratory | 0.016 |
NR-Aromatase | 0.014 |
Antiviral | Yes |
Prediction | 0.84145 |